Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
about
Emerging preclinical pharmacological targets for Parkinson's diseaseNicotine from cigarette smoking and diet and Parkinson disease: a review.Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeysAnalysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairmentsα7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.Levodopa-induced dyskinesias in Parkinson's disease: emerging treatmentsEffect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release.Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.The striatal cholinergic system in L-dopa-induced dyskinesias.
P2860
Q26764724-FCDA8D2B-096F-4A9A-A6D2-8C484818C4E2Q33862534-72DFEC4B-BE01-4A2B-A00C-FD51A3B4CA7BQ34112026-45DAD38C-40C0-4E2D-84E1-36C9DCA4C521Q34186299-C5AB1A81-395E-49C9-AF89-70AF9D8037B6Q35836503-1729FD71-A567-4182-A73F-33F6FF9D0E25Q36469995-8DB5E9A7-E70A-49A0-BBE8-9EB304D4038FQ36936930-89938E91-9072-4AF6-984E-99E793319866Q37193201-974C8C23-6672-4021-963E-DFA81E8FD5B1Q37209730-DA770FCF-A56F-47C7-8F5D-535E54C747CAQ37708588-D48EEFB1-24C6-4737-8FA6-65CBA8D5D50EQ38156760-BB0521A8-464A-4F36-88BF-64247053BB97Q38186596-00B603A7-33C2-4E73-8BF5-4BF8ECCBA500Q38532889-29298552-6A69-415A-99F4-DBFCF5662A0AQ38629277-D229B1BF-FB87-4C68-AE47-E64327A491F5Q41510167-73623BBA-251C-4044-89DF-798A92D04F3CQ42640556-FAB47DA9-1FD3-4D57-8A94-38CAAAA90007Q42676936-6804272F-3252-4952-BC2D-7648005C00D8Q42789671-B06814D0-933C-45A5-9BD1-99DE37A7BA2FQ52680310-0D4B9E5B-3D1B-40A0-B819-9B0A9E47182E
P2860
Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nicotine-mediated improvement ...... pamine nerve terminal function
@en
type
label
Nicotine-mediated improvement ...... pamine nerve terminal function
@en
prefLabel
Nicotine-mediated improvement ...... pamine nerve terminal function
@en
P2093
P2860
P1476
Nicotine-mediated improvement ...... pamine nerve terminal function
@en
P2093
Archana Mallela
J Michael McIntosh
Maryka Quik
Matthew Chin
Tanuja Bordia
Xiomara A Perez
P2860
P356
10.1016/J.NBD.2012.09.006
P577
2012-09-23T00:00:00Z